43-year-old woman with diagnosed myasthenia gravis presents with profound skeletal muscle weakness. We are unsure whether she is experiencing a cholinergic crisis or a myasthenic crisis, so we administer a usually appropriate dose of parenteral edrophonium. Assume the patient was actually experiencing a cholinergic crisis. Which of the following is the most likely response to the drug?

43-year-old woman with diagnosed myasthenia gravis presents with profound skeletal muscle weakness. We are unsure whether she is experiencing a cholinergic crisis or a myasthenic crisis, so we administer a usually appropriate dose of parenteral edrophonium. Assume the patient was actually experiencing a cholinergic crisis. Which of the following is the most likely response to the drug?

The following sympathomimetic drug is a catecholamine:

Non-selective ß-blockers are contraindicated in:

Each of the following parasympathomimetics is paired with an appropriate therapeutic use EXCEPT:

Monoamine oxidase enzyme (MAO) is responsible for: